Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and ...

PETALING JAYA: After enduring nine months of early exits, men's doubles pair Choong Hon Jian-Mohd Haikal Nazri now have a golden opportunity to break their jinx when they face Japan's Tori Aizawa ...

Honeywell International Inc. (NASDAQ:HON) is one of the Best Industrial Automation Stocks to Buy for the Next Decade. Barclays analyst Julian Mitchell has raised the firm’s price target on ...

Roche Holding AG said on Tuesday it has paused shipments of muscular disorder gene therapy Elevidys in some countries outside the U.S., echoing a similar decision by U.S. partner Sarepta ...

Shares of beleaguered drugmaker Sarepta Therapeutics jumped in afterhours trading Monday after the company said it would resume shipping its gene therapy for some patients, following a brief pause ...

Sarepta Therapeutics faces a challenging period as it navigates recent setbacks with its groundbreaking gene therapy, leading to workforce reductions across multiple locations.

Sarepta will continue to ship its gene therapy Elevidys to DMD patients who can still walk independently, arguing the data support the drug's safety.

Hon Hai is Apple's largest manufacturing partner and is instrumental to the assembly of iPhones and other devices.

Sarepta has also announced an FDA-requested black box warning be included on Elevidys’ label for acute liver injury and failure.

Operator: Good day, and welcome to the CNX Resources Second Quarter 2025 Q&A Conference Call. [Operator Instructions] Please note this event is being recorded.